Aysin Kokturk

Aysin Kokturk

Auto-generated profile, based on publicly available information

Aysin Kokturk

Department of Dermatology, Faculty of Medicine, Mersin University, Mersin, Turkey

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2003 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
AKAysin Kokturk
Aysin Kokturk
KBKiymet Baz
Kiymet Baz
RBResul Bugdayci
Resul Bugdayci
TSTayyar Sasmaz
Tayyar Sasmaz
UTUmit Tursen
Umit Tursen
GIGuliz Ikizoglu
Guliz Ikizoglu

1 January 2003 in Dermatology Online Journal
Verified
Journal Article
Closed access
AKAysin Kokturk
Aysin Kokturk
TKTamer Irfan Kaya
Tamer Irfan Kaya
KBKiymet Baz
Kiymet Baz
AYAyca Cordan Yazici
Ayca Cordan Yazici
DADuygu Dusmez Apa
Duygu Dusmez Apa
GIGuliz Ikizoglu
Guliz Ikizoglu
Author(s): Kokturk, Aysin, MD; Kaya, Tamer Irfan, MD; Baz, Kiymet, MD; Yazici, Ayca Cordan, MD; Apa, Duygu Dusmez, MD; Ikizoglu, Guliz, MD

15 April 2004 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
AKA Kokturk
A Kokturk
GIG Ikizoglu
G Ikizoglu
TKTi Kaya
Ti Kaya
KBK Baz
K Baz
BUB Ulubas
B Ulubas
DADd Apa
Dd Apa

1 January 2002 in Journal of Dermatological Treatment
Verified
Journal Article
Closed access
AKA Kokturk
A Kokturk
TKTi Kaya
Ti Kaya
GIG Ikizoglu
G Ikizoglu
RBR Bugdayci
R Bugdayci
AKA Koca
A Koca
BACKGROUND: Itraconazole is an oral antifungal agent, which has been proved to be effective in pityriasis versicolor. Different regimens for the treatment of pityriasis versicolor have been studied and good results were obtained with short-term treatment regimens. OBJECTIVE: To compare the efficacy and tolerability of the classical regimen of 200 mg/day itraconazole for 5 days with the regimes of 400 mg/day for 1 and 3 days. METHODS: A total of 60 patients with pityriasis versicolor were recruited into a randomized study. The patients were divided into three groups, each composed of 20 people. Mycological and clinical assessments were done before and on the 7th and 28th days after treatment. Results were evaluated with the chi-squared test. RESULTS: The regimen of 400 mg/day itraconazole for 3 days was found to be as effective as the classical regimen of 200 mg/day for 5 days in the treatment of pityriasis versicolor. The regimen of 400 mg/day itraconazole for 1 day was found to be ineffective. CONCLUSION: This study has shown that a short course of itraconazole, 400 mg/day for 3 days, appears to be an effective and alterantive treatment for pityriasis versicolor.

19 February 2004 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Closed access
PDF file
KBK Baz
K Baz
AKA Kokturk
A Kokturk
TKTi Kaya
Ti Kaya
GIG Ikizoglu
G Ikizoglu
AYAc Yazici
Ac Yazici
EBE Bocekli
E Bocekli

1 April 2003 in International Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
KBKiymet Baz
Kiymet Baz
AKAysin Kokturk
Aysin Kokturk
TKTamer İrfan Kaya
Tamer İrfan Kaya
GIGuliz Ikizoglu
Guliz Ikizoglu
DDDuygu Dusmez
Duygu Dusmez
AKAynur Koca
Aynur Koca